preclinical white papers and articles

  1. Epidermolysis Bullosa: Future Perspectives In Drug Development 1/14/2025

    Recent breakthroughs are signaling a promising shift in the landscape of Epidermolysis bullosa (EB) care from focusing on pain management to a growing commitment to curative strategies.

  2. Gene Therapy In Neurology: The Case For Optimism 1/14/2025

    Advancements in genetic therapy are revolutionizing the treatment of neurological diseases, with promising results from preclinical studies leading to clinical trials focused on safety and efficacy.

  3. Overview Of Parkinson's Disease: Global Clinical Trials Landscape 12/27/2024

    Parkinson's disease affects over 8.5 million globally. Explore how advances in gene therapy, Deep Brain Stimulation, and innovative drugs are transforming treatment and improving patient outcomes.

  4. Overview Of COVID-19: Global Clinical Trial Landscape 12/27/2024

    Explore how COVID-19 has led to significant global morbidity and mortality. Advances in vaccines, therapies, and clinical trials are enhancing disease management and outcomes.

  5. Antibody-Drug Conjugates In Oncology: Revolutionizing Cancer Treatment 11/20/2024

    ADCs are reshaping cancer treatment by combining targeted delivery with potent cell-killing agents. Learn how these therapies offer new hope for patients and exciting opportunities for drug developers.

  6. Managing The Complexities Of Glucagon-Like Peptide-1 Receptor Agonist Drug Development 11/20/2024

    Dive into the dynamic world of GLP-1 receptor agonists, where we explore the current landscape, the challenges ahead and the complexities of early-phase drug development.

  7. Toxicokinetics, Pharmacokinetics, And Pharmacodynamics 11/20/2024

    Discover why gathering and analyzing pharmacokinetic (PK) and pharmacodynamic (PD) data is key — from preclinical studies right to clinical trial conduct.

  8. Overview Of Bladder Cancer: Global Clinical Trials Landscape 11/15/2024

    Advances in immunotherapy, targeted drugs, and clinical trials are improving outcomes for bladder cancer patients, addressing regional disparities and accessibility challenges worldwide.

  9. Overview Of Small Cell Lung Cancer: Global Clinical Trial Landscape 11/15/2024

    Small cell lung cancer (SCLC) is a fast-growing, aggressive lung cancer subtype. Global incidence, innovative therapies, and personalized medicine are transforming treatment outcomes and survival rates.

  10. Overview Of Diffuse Large B-cell Lymphoma: Global Clinical Trial Landscape 11/15/2024

    Diffuse large B-cell lymphoma (DLBCL), the most common non-Hodgkin lymphoma subtype, has varied molecular profiles, global incidence, innovative drugs, and trials improving treatment strategies and patient outcomes.